A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Erimos Pharmaceuticals.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Erimos Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00664586
First received: April 21, 2008
Last updated: January 29, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2009
  Estimated Primary Completion Date: No date given